Codes / ICD10CM / H25.20

H25.20 Age-related cataract, morgagnian type, unspecified eye

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Age-related Cataract, Morgagnian Type, Unspecified Eye
  • Technical term: H25.20

Summary

Age-related cataract, morgagnian type, unspecified eye, is a specific form of cataract characterized by the liquefaction of the lens nucleus and sinking of dense, opaque material within the lens capsule. This condition typically occurs in advanced stages of cataract development and may lead to significant visual impairment. The liquefied cortex and displaced nucleus can cause rapid changes in vision and increase the risk of complications during surgical intervention.

Causes

The primary cause is advanced age-related degeneration of the lens, leading to the breakdown of lens proteins and fibers. Over time, the nucleus becomes hypermature, and the surrounding cortex liquefies, allowing the dense nuclear material to sink inferiorly within the lens capsule. This process is part of the natural progression of untreated or long-standing cataracts.

Risk Factors

  • Advanced age: Most common in older adults with long-standing cataracts.
  • Prolonged untreated cataracts: Increases the likelihood of nuclear liquefaction.
  • Ocular trauma or inflammation: May accelerate lens degeneration.
  • Systemic conditions: Diabetes or other metabolic disorders can contribute to lens changes.

Symptoms

  • Sudden or rapid decline in vision.
  • Increased glare sensitivity, especially in bright light.
  • Difficulty with low-light vision.
  • Possible changes in prescription strength.
  • Visual distortion or double vision in some cases.

Diagnosis

Diagnosis involves a comprehensive eye examination, including visual acuity testing, slit-lamp examination, and dilated fundus evaluation to assess lens opacity and rule out other ocular conditions. The presence of a hypermature lens with liquefied cortex and displaced nucleus confirms the diagnosis.

Treatment Options

  • Surgical intervention: Phacoemulsification with intraocular lens implantation is the standard treatment for symptomatic cases.
  • Preoperative assessment: Careful evaluation to manage increased surgical risks due to lens changes.
  • Postoperative care: Monitoring for complications such as inflammation or intraocular pressure changes.

Prognosis and Follow-Up

Prognosis is generally good with timely surgical intervention, as vision typically improves significantly. Follow-up appointments are necessary to monitor for complications and ensure proper healing. Long-term outcomes depend on the absence of additional ocular conditions.

Complications

  • Increased surgical difficulty: Liquefied cortex may complicate lens removal.
  • Postoperative inflammation: Higher risk of intraocular inflammation.
  • Secondary glaucoma: Potential elevation of intraocular pressure.
  • Retinal detachment: Rare but possible complication.

Lifestyle & Prevention

  • UV protection: Wearing sunglasses to reduce cumulative lens damage.
  • Healthy diet: Consuming antioxidants (e.g., vitamins C and E) may support lens health.
  • Regular eye exams: Early detection of cataract progression.
  • Manage systemic conditions: Controlling diabetes or hypertension to reduce lens stress.

When to Seek Professional Help

Seek immediate medical attention if experiencing sudden vision loss, severe glare sensitivity, or pain, as these may indicate complications requiring urgent intervention.

Tips for Medical Coders

Document the specific eye (unspecified in this code) and confirm the morgagnian type characteristics (liquefied cortex, displaced nucleus) to support accurate coding. Ensure clinical documentation aligns with the advanced stage of cataract development implied by this code.

Book a walkthrough

H25.20 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.